首页|Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma:Past,present,and future directions

Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma:Past,present,and future directions

扫码查看
原文链接
  • 国家科技期刊平台
  • NETL
  • NSTL
  • 万方数据
Intrahepatic cholangiocarcinoma(iCCA)is a rare biliary tract cancer with high mortality rate.Complete resection of the iCCA lesion is the first choice of treatment,with good prognosis after margin-negative re-section.Unfortunately,only 12％-40％of patients are eligible for resection at presentation due to cirrhosis,portal hypertension,or large tumor size.Liver transplantation(LT)offers margin-negative iCCA extirpa-tion for patients with unresectable tumors.Initially,iCCA was a contraindication for LT until size-based selection criteria were introduced to identify patients with satisfied post-LT outcomes.Recent studies have shown that tumor biology-based selection can yield high post-LT survival in patients with locally advanced iCCA.Another selection criterion is the tumor response to neoadjuvant therapy.Patients with response to neoadjuvant therapy have better outcomes after LT compared with those without tumor re-sponse to neoadjuvant therapy.Another index that helps predict the treatment outcome is the biomarker.Improved survival outcomes have also opened the door for living donor LT for iCCA.Patients undergoing LT for iCCA now have statistically similar survival rates as patients undergoing resection.The combination of surgery and locoregional and systemic therapies improves the prognosis of iCCA patients.

Liver transplantationCholangiocarcinomaHepatectomyTransplant oncologyLiver neoplasm

Sudha Kodali、Ashton A Connor、Souhail Thabet、Elizabeth W Brombosz、R Mark Ghobrial

展开 >

Sherrie and Alan Conover Center for Liver Disease and Transplantation,Houston Methodist Hospital,Houston,TX 77030,USA

JC Walter Jr Transplant Center,Houston Methodist Hospital,Houston,TX 77030,USA

Department of Medicine,Weill Cornell Medical College,New York,NY,USA

Department of Surgery,Houston Methodist Hospital,Houston,TX 77030,USA

Department of Surgery,Weill Cornell Medical College,New York,NY,USA

School of Medicine,New Giza University,Giza,Egypt

展开 >

2024

10.1016/j.hbpd.2023.07.007

国际肝胆胰疾病杂志(英文版)
浙江省医学学术交流管理中心,浙江大学医学院附属第一医院,浙江大学出版社有限责任公司

国际肝胆胰疾病杂志(英文版)

影响因子：0.668
ISSN：1499-3872
年,卷(期)：2024.23(2)
  • 105